BSF Enterprise PLC’s Kerato Ltd Partners with University of Montreal to Develop Novel Corneal Damage Treatment

A Major Breakthrough in Eye Health

In a groundbreaking partnership, BSF Enterprise PLC's Kerato Ltd has joined forces with the esteemed University of Montreal to develop a revolutionary treatment for corneal damage. This collaboration marks a significant milestone in the field of ophthalmology, bringing together the expertise and resources of two leading institutions to address a pressing unmet medical need.

Transforming Eye Health

Corneal damage is a debilitating condition that can lead to significant vision impairment and even blindness. Currently, treatment options are limited and often invasive. The partnership between Kerato Ltd and the University of Montreal aims to change this paradigm by developing a novel, non-invasive treatment that has the potential to restore corneal function and improve vision outcomes for patients worldwide.